Investor List:

Top Diagnostics Series A Investors in San Francisco Bay Area (69)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Geoffrey Smith, Managing Partner at Digitalis Ventures
Geoffrey Smith
Digitalis Ventures·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in New York (NY), Investors in Los Angeles (CA), Investors in San Francisco (CA), Investors in Boston (MA)
Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Therapeutics (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Series B), Investors in Diagnostics (Seed), Investors in Therapeutics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Therapeutics (Series B), Investors in Therapeutics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Therapeutics (Series A), Investors in Therapeutics (Seed), Investors in Therapeutics (Series A), Investors in Therapeutics (Series A), Investors in Manufacturing (Series B), Investors in Manufacturing (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Therapeutics (Seed), Investors in Therapeutics (Seed), Investors in BioTech (Series B), Investors in Manufacturing (Series A), Investors in Digital Health (Series B), Investors in Manufacturing (Series B), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in Digital Health (Series B), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in Digital Health (Series A), Investors in Manufacturing (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Seed), Investors in Manufacturing (Series A), Investors in Manufacturing (Seed), Investors in Manufacturing (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Manufacturing (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Manufacturing (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Manufacturing (Seed), Investors in Manufacturing (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Digital Health (Series B), Investors in Manufacturing (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Digital Health (Series A), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Health IT (Series A), Investors in BioTech (Series A), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Los Angeles / Southern California (Other Lists), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Jason G., Investor at B Capital Group
Jason G.
B Capital Group·Investor
Sweet spot: $25.0M
Range: $25.0M - $60.0M
Investors in SF Bay Area (CA)
Photo of Ling Wong, General Partner at Highbury Group
Ling Wong
Highbury Group·General Partner
Sweet spot: $10.0M
Range: $500K - $50.0M
Investors in San Francisco (CA), Investors in Seattle (WA)
Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Diagnostics (Series A), Investors in Health & Hospital Services (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Diagnostics (Seed), Investors in Health IT (Series B), Investors in Generative Tech/AI (Series B), Investors in BioTech (Series A), Investors in Digital Health (Seed), Investors in Generative Tech/AI (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Consumer Health (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Generative Tech/AI (Seed), Investors in BioTech (Seed), Investors in Diagnostics (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Consumer Health (Seed), Investors in Consumer Health (Series A), Investors in Enterprise (Series B), Investors in Pharmaceuticals (Series B), Investors in Health IT (Seed), Investors in Generative Tech/AI (Series B), Investors in Enterprise (Series A), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Generative Tech/AI (Series B), Investors in Generative Tech/AI (Series A), Investors in Pharmaceuticals (Series B), Investors in Enterprise (Seed), Investors in Generative Tech/AI (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in Generative Tech/AI (Series A), Investors in Consumer Health (Series B), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Generative Tech/AI (Seed), Investors in Consumer Health (Series B), Investors in Digital Health (Series A), Investors in BioTech (Series B), Investors in Digital Health (Seed), Investors in ClimateTech/CleanTech (Series B), Investors in ClimateTech/CleanTech (Series A), Investors in Health & Hospital Services (Series B), Investors in Consumer Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in ClimateTech/CleanTech (Seed), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Consumer Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in Health IT (Seed), Investors in ClimateTech/CleanTech (Series A), Investors in BioTech (Series A), Investors in Enterprise (Series B), Investors in ClimateTech/CleanTech (Seed), Investors in Seattle / Portland (Other Lists), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Enterprise (Series B), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in Enterprise (Series A), Investors in Enterprise (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Rebecca Woodcock, Principal at Yamaha Motor Ventures
Rebecca Woodcock
Sweet spot: $1.5M
Range: $500K - $5.0M
Investors in SF Bay Area (CA), Investors in San Francisco (CA)
Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Wellness & Fitness (Series A), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Digital Health (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in BioTech (Series A), Investors in AI (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health IT (Series A), Investors in Consumer Internet (Series A), Investors in Health & Hospital Services (Seed), Investors in AI (Seed), Investors in Consumer Internet (Seed), Investors in Health IT (Seed), Investors in AI (Series A), Investors in AI (Seed), Investors in Female Investors (Other Lists), Investors in Consumer Internet (Series A), Investors in Consumer Internet (Seed), Investors in Diverse Investors (Other Lists), Investors in Investors who were founders (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Photo of Anne DeGheest, Managing Director at Healthtech Capital
Anne DeGheest
Healthtech Capital·Managing Director
Sweet spot: $300K
Range: $10K - $1.5M
Investors in Diagnostics (Series A), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Diagnostics (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Direct-to-Consumer (DTC) (Series A), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Direct-to-Consumer (DTC) (Seed), Investors in Wellness & Fitness (Series A), Investors in Wellness & Fitness (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Female Investors (Other Lists), Investors in Digital Health (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Series A), Investors in Consumer Health (Seed), Investors in Diverse Investors (Other Lists), Investors in Health & Hospital Services (Series A), Investors in Investors who were founders (Other Lists), Investors in Digital Health (Series A), Investors in Health & Hospital Services (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in Consumer Health (Series A), Investors in Health IT (Series A), Investors in Digital Health (Seed), Investors in Consumer Health (Seed), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Jenny Rooke, Managing Director at Genoa Ventures
Jenny Rooke
Genoa Ventures·Managing Director
Sweet spot: $2.0M
Range: $250K - $10.0M
Investors in San Francisco (CA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Kevin Koch, Venture Partner at OrbiMed
Kevin Koch
OrbiMed·Venture Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in San Francisco (CA), Investors in New York
Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in Medical Devices (Series A), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in Colorado / Utah (Other Lists), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Photo of Peter Thompson, Partner at OrbiMed
Peter Thompson
OrbiMed·Partner
Sweet spot: $4.0M
Range: $1M - $75.0M
Investors in New York (NY), Investors in San Francisco (CA)